mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
COVID-19 vaccine development and a potential nanomaterial path forward | Nature Nanotechnology
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
Frontiers | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections | Immunology
PDF) mRNA vaccines — a new era in vaccinology
PDF) Modified mRNA Vaccines Protect against Zika Virus Infection
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
Moncef Slaoui - Wikipedia
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
FDA approves potential COVID-19 vaccine by Moderna for second-stage study - UPI.com
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post
PDF) Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
PDF) Generating an Anti-HIV Vaccine Using Nucleoside-modified mRNA Encoding Envelope
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
